European Association for Hemophilia and Allied Disorders (EAHAD 2026)
European Association for Hemophilia and Allied Disorders (EAHAD 2026) 3 - 6 February 2026

Concizumab efficacy in Haemophilia A/B in an Intra-Patient Comparison vs Previous prophylaxis (Phase 3 Explorer8 study): Post-hoc Sensitivity Analysis

Authors :

Hermann Eichler1, Anthony KC Chan2, Renée Brown Frandsen3, Fernanda Martinez Garcia3, Allison P Wheeler4, Pratima Chowdary5
Affiliations
View Details Hide Details
Download poster (.pdf)
Keywords
Rare Blood Disorders
Congress poster
Concizumab